ANGION BIOMEDICA CORP - COM (ANGN)

CUSIP: 03476J107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
7,015,664
Share change
-74,941
Total reported value
$20,322,000
Price per share
$2.90
Number of holders
52
Value change
-$14,478,442
Number of buys
31
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 03476J107?
CUSIP 03476J107 identifies ANGN - ANGION BIOMEDICA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ANGION BIOMEDICA CORP - COM (ANGN) as of Q4 2021

As of 31 Dec 2021, ANGION BIOMEDICA CORP - COM (ANGN) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,015,664 shares. The largest 10 holders included Nantahala Capital Management, LLC, BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, Russell Investments Group, Ltd., LAKE STREET ADVISORS GROUP, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and NORTHERN TRUST CORP. This page lists 52 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.